371 related articles for article (PubMed ID: 22915242)
1. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.
Abe H; Maeda D; Hino R; Otake Y; Isogai M; Ushiku AS; Matsusaka K; Kunita A; Ushiku T; Uozaki H; Tateishi Y; Hishima T; Iwasaki Y; Ishikawa S; Fukayama M
Virchows Arch; 2012 Oct; 461(4):367-77. PubMed ID: 22915242
[TBL] [Abstract][Full Text] [Related]
2. Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
Han N; Kim MA; Lee HS; Kim WH
Appl Immunohistochem Mol Morphol; 2016; 24(5):320-5. PubMed ID: 26067140
[TBL] [Abstract][Full Text] [Related]
3. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
Abe H; Kunita A; Otake Y; Kanda T; Kaneda A; Ushiku T; Fukayama M
PLoS One; 2021; 16(9):e0256440. PubMed ID: 34469459
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer.
Kim JY; Park CK; Noh S; Cheong JH; Noh SH; Kim H
Gut Liver; 2023 Sep; 17(5):753-765. PubMed ID: 36789575
[TBL] [Abstract][Full Text] [Related]
5. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.
Bosse T; ter Haar NT; Seeber LM; v Diest PJ; Hes FJ; Vasen HF; Nout RA; Creutzberg CL; Morreau H; Smit VT
Mod Pathol; 2013 Nov; 26(11):1525-35. PubMed ID: 23702729
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma.
Herath CH; Chetty R
Arch Pathol Lab Med; 2008 Apr; 132(4):706-9. PubMed ID: 18384225
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
[TBL] [Abstract][Full Text] [Related]
9. Unique characteristics of
Kim YS; Jeong H; Choi JW; Oh HE; Lee JH
Saudi J Gastroenterol; 2017; 23(5):268-274. PubMed ID: 28937020
[TBL] [Abstract][Full Text] [Related]
10. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression.
Huang SC; Ng KF; Yeh TS; Cheng CT; Chen MC; Chao YC; Chuang HC; Liu YJ; Chen TC
Histopathology; 2020 Aug; 77(2):250-261. PubMed ID: 32343857
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma.
Zhou H; Tan S; Li H; Lin X
Mol Med Rep; 2019 Mar; 19(3):2125-2136. PubMed ID: 30747208
[TBL] [Abstract][Full Text] [Related]
13. Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer.
Kim YB; Ahn JM; Bae WJ; Sung CO; Lee D
Int J Cancer; 2019 Aug; 145(4):916-926. PubMed ID: 30664822
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.
Ferrasi AC; Pinheiro NA; Rabenhorst SH; Caballero OL; Rodrigues MA; de Carvalho F; Leite CV; Ferreira MV; Barros MA; Pardini MI
World J Gastroenterol; 2010 Jan; 16(3):312-9. PubMed ID: 20082476
[TBL] [Abstract][Full Text] [Related]
15. Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer.
Zhu YP; Sheng LL; Wu J; Yang M; Cheng XF; Wu NN; Ye XB; Cai J; Wang L; Shen Q; Wu JQ
Hum Pathol; 2018 Aug; 78():28-35. PubMed ID: 29689245
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
Tober JM; Halske C; Behrens HM; Krüger S; Röcken C
Hum Pathol; 2019 Dec; 94():98-109. PubMed ID: 31704366
[TBL] [Abstract][Full Text] [Related]
17. Various ARID1A expression patterns and their clinical significance in gastric cancers.
Kim YB; Ham IH; Hur H; Lee D
Hum Pathol; 2016 Mar; 49():61-70. PubMed ID: 26826411
[TBL] [Abstract][Full Text] [Related]
18. An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes.
Tsai JH; Jeng YM; Chen KH; Lee CH; Yuan CT; Liau JY
Am J Surg Pathol; 2020 Aug; 44(8):1017-1030. PubMed ID: 32568823
[TBL] [Abstract][Full Text] [Related]
19. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.
Wang K; Kan J; Yuen ST; Shi ST; Chu KM; Law S; Chan TL; Kan Z; Chan AS; Tsui WY; Lee SP; Ho SL; Chan AK; Cheng GH; Roberts PC; Rejto PA; Gibson NW; Pocalyko DJ; Mao M; Xu J; Leung SY
Nat Genet; 2011 Oct; 43(12):1219-23. PubMed ID: 22037554
[TBL] [Abstract][Full Text] [Related]
20. Stage IV early gastric cancer: two cases with microsatellite instability.
An JY; Choi MG; Noh JH; Kim KM; Kim DS; Sohn TS; Kim S
Langenbecks Arch Surg; 2008 Jan; 393(1):105-9. PubMed ID: 17917741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
